Clinical Trials Logo

Communication Disorder clinical trials

View clinical trials related to Communication Disorder.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02909088 Recruiting - Speech Disorders Clinical Trials

Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).

Start date: September 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the efficacy and tolerability of ecopipam in reducing stuttering symptoms. It is hypothesized that ecopipam effectively reduces stuttering symptoms as measured on the SSI-IV total score, the CGI, SSS and OASES.